TFX Teleflex Incorporated

163.40USD-1.48%Mkt Cap: 6.48B USDP/E: 80.49

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the…

Institutional holders20 on file

Key Statistics

Company
Market Cap6.48B USD
Enterprise Value7.84B USD
Revenue (TTM)2.26B USD
Gross Profit1.12B USD
Net Income (TTM)-905.64M USD
Revenue/Share52.00 USD
Last Price163.40 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees15.5K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)80.49
P/E (Forward)14.93
PEG0.16
EV/EBITDA16.61
EV/Revenue3.48
P/S2.87
P/B1.89
EPS (TTM)2.03 USD
EPS (Forward)10.94 USD
52W Range
100.1895% of range166.75
52W High166.75 USD
52W Low100.18 USD
Profitability
Gross Margin56.24%
Oper. Margin11.68%
EBITDA Margin20.93%
Profit Margin-45.45%
ROE-28.98%
ROA-13.04%
ROIC4.67%
ROCE4.14%
Growth
Revenue Growth0.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF340.68M USD
CapEx (TTM)95.24M USD
FCF Margin30.70%
FCF Yield10.68%
Net Debt1.26B USD
Net Debt/EBITDA2.67
Net Debt/FCF1.82
Balance Sheet
Debt/Equity0.87
Current Ratio2.01
Quick Ratio0.91
Book Value/Sh86.30 USD
Cash/Share11.52 USD
Dividends
Fwd Div Rate1.36 USD
Trail. Div Rate1.36 USD
Div. Yield0.82%
5Y Avg Yield0.68%
Payout Ratio67.00%
Ex-Div DateNov 16, 2026
Pay DateDec 31, 2026
Splits
Last Split2:1
Split DateJun 17, 1997
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)168.09 USD
Upside (mean)+2.9%
Target Range158.00 USD – 178.00 USD
158.00+2.9% to mean178.00
# Analysts11
Ownership
Shares Out.39.66M
Float39.50M
Insiders0.67%
Institutions116.35%
Short Interest
Short Ratio5.8d
Short % Float15.05%
Short % Out.9.60%
Shares Short4.07M
Short (prev mo.)4.05M
Technical
SMA 50133.94 (+22.0%)
SMA 200127.77 (+27.9%)
Beta0.83
S&P 52W Chg12.08%
Avg Vol (30d)819.13K
Avg Vol (10d)951.71K
Technical Indicators
RSI (14)75.7
MACD7.7771
MACD Signal6.6481
MACD Hist.+1.1290
BB Upper168.04 USD
BB Middle149.31 USD
BB Lower130.58 USD
BB Width25.09%
ATR (14)4.679 USD
Vol Ratio (20d)1.00x

About Teleflex (NYSE: TFX)

›

Teleflex (NYSE: TFX) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 15,500 employees.

The shares were at 163.40 USD on 19 November 2026, up 53.5% over 52 weeks. Its 52-week range is 100.18 USD to 166.75 USD: the price is 2.0% below the high and 63.1% above the low.

At a market capitalisation of 6.48B USD, it trades at 80.5 times trailing earnings and 14.9 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a premium of 63% for TFX. It pays a dividend yielding 0.82% (it pays out 67% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Teleflex reports return on equity of -29.0%, an operating margin of 11.7% and flat revenue year over year.

Its debt exceeds its cash by 1.26B USD, a debt-to-equity ratio of 0.87. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 11 analysts cover the stock, with an average rating of Buy; their mean price target of 168.09 USD is 2.9% above the current price. The next earnings report is expected on 25 February 2027.